WAO consensus on DEfinition of Food Allergy SEverity (DEFASE).
Consensus
Definition
Food allergy
Severity
e-Delphi study
Journal
The World Allergy Organization journal
ISSN: 1939-4551
Titre abrégé: World Allergy Organ J
Pays: United States
ID NLM: 101481283
Informations de publication
Date de publication:
Mar 2023
Mar 2023
Historique:
received:
15
09
2022
revised:
20
01
2023
accepted:
03
02
2023
entrez:
13
3
2023
pubmed:
14
3
2023
medline:
14
3
2023
Statut:
epublish
Résumé
While several scoring systems for the severity of anaphylactic reactions have been developed, there is a lack of consensus on definition and categorisation of severity of food allergy disease as a whole. To develop an international consensus on the severity of food allergy (DEfinition of Food Allergy Severity, DEFASE) scoring system, to be used globally. We conducted a mixed-method systematic review (SR) of 11 databases for published and unpublished literature on severity of food allergy management and set up a panel of international experts. Based on our findings in Phase 1, we drafted statements for a two-round modified electronic Delphi (e-Delphi) survey. A purposefully selected multidisciplinary international expert panel on food allergy (n = 60) was identified and sent a structured questionnaire, including a set of statements on different domains of food allergy severity related to symptoms, health-related quality of life, and economic impact. Participants were asked to score their agreement on each statement on a 5-point Likert scale ranging from "strongly agree" to "strongly disagree". Median scores and percentage agreements were calculated. Consensus was defined We received responses from 92% of Delphi panel members in round 1 and 85% in round 2. Consensus was achieved on the overall score and in all of the 5 specific key domains as essential components of the DEFASE score. The DEFASE score is the first comprehensive grading of food allergy severity that considers not only the severity of a single reaction, but the whole disease spectrum. An international consensus has been achieved regarding a scoring system for food allergy disease. It offers an evaluation grid, which may help to rate the severity of food allergy. Phase 3 will involve validating the scoring system in research settings, and implementing it in clinical practice.
Sections du résumé
Background
UNASSIGNED
While several scoring systems for the severity of anaphylactic reactions have been developed, there is a lack of consensus on definition and categorisation of severity of food allergy disease as a whole.
Aim
UNASSIGNED
To develop an international consensus on the severity of food allergy (DEfinition of Food Allergy Severity, DEFASE) scoring system, to be used globally.
Methods Phase 1
UNASSIGNED
We conducted a mixed-method systematic review (SR) of 11 databases for published and unpublished literature on severity of food allergy management and set up a panel of international experts.
Phase 2
UNASSIGNED
Based on our findings in Phase 1, we drafted statements for a two-round modified electronic Delphi (e-Delphi) survey. A purposefully selected multidisciplinary international expert panel on food allergy (n = 60) was identified and sent a structured questionnaire, including a set of statements on different domains of food allergy severity related to symptoms, health-related quality of life, and economic impact. Participants were asked to score their agreement on each statement on a 5-point Likert scale ranging from "strongly agree" to "strongly disagree". Median scores and percentage agreements were calculated. Consensus was defined
Results
UNASSIGNED
We received responses from 92% of Delphi panel members in round 1 and 85% in round 2. Consensus was achieved on the overall score and in all of the 5 specific key domains as essential components of the DEFASE score.
Conclusions
UNASSIGNED
The DEFASE score is the first comprehensive grading of food allergy severity that considers not only the severity of a single reaction, but the whole disease spectrum. An international consensus has been achieved regarding a scoring system for food allergy disease. It offers an evaluation grid, which may help to rate the severity of food allergy. Phase 3 will involve validating the scoring system in research settings, and implementing it in clinical practice.
Identifiants
pubmed: 36910595
doi: 10.1016/j.waojou.2023.100753
pii: S1939-4551(23)00013-3
pmc: PMC9996094
doi:
Types de publication
Journal Article
Langues
eng
Pagination
100753Informations de copyright
© 2023 The Authors.
Références
J Allergy Clin Immunol Pract. 2020 Jan;8(1):75-90.e17
pubmed: 31950914
Front Immunol. 2018 Sep 21;9:2057
pubmed: 30298065
Allergy. 2020 Nov;75(11):2734-2752
pubmed: 32558994
J Allergy Clin Immunol. 2021 Jul;148(1):173-181
pubmed: 33476673
J Allergy Clin Immunol. 2021 Dec;148(6):1526-1532
pubmed: 34048855
World Allergy Organ J. 2016 Aug 09;9:24
pubmed: 27551327
Allergy. 2016 Feb;71(2):135-6
pubmed: 26381421
BMC Complement Med Ther. 2020 Jan 15;20(1):10
pubmed: 32020878
Allergy. 2022 May;77(5):1545-1558
pubmed: 34716996
J Allergy Clin Immunol. 2007 Apr;119(4):1018-9
pubmed: 17349682
Expert Rev Clin Immunol. 2018 Apr;14(4):307-314
pubmed: 29513116
Ann Allergy Asthma Immunol. 2015 Sep;115(3):217-223.e2
pubmed: 26112147
Clin Exp Allergy. 2012 Jan;42(1):30-7
pubmed: 22093016
Food Chem Toxicol. 2020 Dec;146:111831
pubmed: 33166672
Allergy. 2022 Feb;77(2):357-377
pubmed: 34343358
JAMA Netw Open. 2019 Jan 4;2(1):e185630
pubmed: 30646188
Allergy. 2014 Jan;69(1):62-75
pubmed: 24205824
BMJ Open. 2018 Sep 19;8(9):e024161
pubmed: 30232116
World Allergy Organ J. 2021 Mar 11;14(3):100503
pubmed: 33767801
Allergy. 2018 Sep;73(9):1792-1800
pubmed: 29331045
Allergy. 2016 Sep;71(9):1241-55
pubmed: 27138061
PLoS One. 2017 May 15;12(5):e0164849
pubmed: 28505187
Pediatr Allergy Immunol. 2022 Jan;33(1):e13695
pubmed: 34779046
Inform Prim Care. 2005;13(1):3-12
pubmed: 15949170
J Investig Allergol Clin Immunol. 2021 Apr 20;31(2):132-144
pubmed: 31638577
J Allergy Clin Immunol. 2021 Nov;148(5):1307-1315
pubmed: 33862009
Eur J Pediatr. 2019 Jan;178(1):69-75
pubmed: 30269250
Eur Respir J. 2014 Feb;43(2):343-73
pubmed: 24337046
Pediatrics. 2018 Dec;142(6):
pubmed: 30455345
Pediatr Allergy Immunol. 2010 Jun;21(4 Pt 1):603-11
pubmed: 20444154
Pediatrics. 2003 Jun;111(6 Pt 3):1601-8
pubmed: 12777599
Int J Obes (Lond). 2019 Dec;43(12):2573-2586
pubmed: 30655580
Allergy. 2022 Sep;77(9):2634-2652
pubmed: 35441718
J Allergy Clin Immunol. 2004 Aug;114(2):371-6
pubmed: 15316518
J Allergy Clin Immunol. 2020 Jan;145(1):70-80.e3
pubmed: 31627910
J Adv Nurs. 2000 Oct;32(4):1008-15
pubmed: 11095242
Pediatr Allergy Immunol. 2022 Jan;33(1):e13692
pubmed: 34724234
J Allergy Clin Immunol. 2020 Apr;145(4):1082-1123
pubmed: 32001253
Clin Transl Allergy. 2016 Sep 30;6:37
pubmed: 27733903
Allergy Asthma Proc. 2017 Mar 1;38(2):88-91
pubmed: 28234046
J Allergy Clin Immunol. 2022 Jun;149(6):2166-2170.e1
pubmed: 35026206
J Am Acad Dermatol. 2014 Feb;70(2):338-51
pubmed: 24290431
World Allergy Organ J. 2020 Oct 30;13(10):100472
pubmed: 33204386